SCHEMBL2327792

SCHEMBL2327792

COC(=O)[C@H](CNC(C)=O)Cc1ccccc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTNR1A P48039 4/20 0.59
MTNR1B P49286 4/20 0.59
F10 P00742 1/20 0.50
PRSS1 P07477 1/20 0.50
ATM Q13315 1/20 0.50
CYP1A2 P05177 1/20 0.49
POLB P06746 1/20 0.48
KMT2A Q03164 1/20 0.47
CA12 O43570 1/20 0.46
CA2 P00918 1/20 0.46
CA7 P43166 1/20 0.46
CA9 Q16790 1/20 0.46
CA14 Q9ULX7 1/20 0.46
CTRB1 P17538 1/20 0.46
ALDH1A1 P00352 1/20 0.46
THRB P10828 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
HSD17B10 Q99714 1/20 0.46
MAPT P10636 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2327788 1.00 MTNR1A (0.59) MTNR1AMTNR1BF10PRSS1ATM
SCHEMBL1709763 0.85 MTNR1A (0.64) MTNR1AMTNR1BCYP1A2KMT2ACTRB1
SCHEMBL4240995 0.84 F10 (0.47) F10PRSS1ATMCYP1A2POLB
SCHEMBL23792351 0.84 F10 (0.53) F10PRSS1ATMCYP1A2POLB
SCHEMBL1187483 0.84 TRPM8 (0.53) F10PRSS1CYP1A2CTRB1ALDH1A1
SCHEMBL1828061 0.83 ALDH1A1 (0.43) MTNR1AMTNR1BF10PRSS1KMT2A
SCHEMBL13816316 0.81 SYK (0.56) F10PRSS1ATMCA12CA7
SCHEMBL117431 0.80 CYP1A2 (0.60) ATMCYP1A2POLBKMT2AALDH1A1
SCHEMBL3596338 0.80 ALDH1A1 (0.57) ATMCYP1A2POLBKMT2AALDH1A1
SCHEMBL20021560 0.80 MTNR1A (0.57) MTNR1AMTNR1BCYP1A2CTRB1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2534161-A1 ENANTIOMERICALLY ENRICHED AMINODIPHOSPHINES AS LIGANDS FOR THE PREPARATION OF CATALYSTS FOR ASYMMETRIC SYNTHESIS Enantia, S.L. (ES) 2012-12-19 EP disclosed
US-20120309997-A1 Enantiomerically Enriched Aminodiphosphines as Ligands for the Preparation of Catalysts for Asymmetric Synthesis ENANTIA, S.L. (ES) 2012-12-06 US disclosed
WO-2011098160-A1 ENANTIOMERICALLY ENRICHED AMINODIPHOSPHINES AS LIGANDS FOR THE PREPARATION OF CATALYSTS FOR ASYMMETRIC SYNTHESIS ENANTIA, S.L. (ES) 2011-08-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120309997-A1 Enantiomerically Enriched Aminodiphosphines as Ligands for the Preparation of Catalysts for Asymmetric Synthesis PHOSPHO1, AASDHPPT, AGPS MTNR1A 3976/4885MTNR1B 4076/4885F10 4464/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.